# LISA-study : Levothyroxin in Nodular Goiter

> **NCT00277589** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 1024 (actual)

## Conditions studied

- Goiter, Nodular

## Interventions

- **DRUG:** Levothyroxin-Na
- **DRUG:** Levothyroxine-Na + iodide
- **DRUG:** Iodide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00277589
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 1024 (ACTUAL)
- **Last updated:** 2009-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277589, "LISA-study : Levothyroxin in Nodular Goiter". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00277589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*